Improving antibiotic dosing in special situations in the ICU: burns, renal replacement therapy and extracorporeal membrane oxygenation

被引:81
作者
Jamal, Janattul-Ain [2 ]
Economou, Caleb J. P. [2 ]
Lipman, Jeffrey [1 ,2 ]
Roberts, Jason A. [2 ,3 ]
机构
[1] Royal Brisbane & Womens Hosp, Burns Trauma & Crit Care Res Ctr, Dept Intens Care Med, Brisbane, Qld 4029, Australia
[2] Univ Queensland, Burns Trauma & Crit Care Res Ctr, Brisbane, Qld, Australia
[3] Royal Brisbane & Womens Hosp, Dept Pharm, Brisbane, Qld 4029, Australia
基金
英国医学研究理事会;
关键词
critical care; extracorporeal membrane oxygenation; pharmacokinetics; renal replacement therapy; sustained low-efficiency dialysis; CRITICALLY-ILL PATIENTS; CARE-UNIT PATIENTS; CONTINUOUS VENOVENOUS HEMOFILTRATION; ACUTE KIDNEY INJURY; INTENSIVE-CARE; POPULATION PHARMACOKINETICS; DORIPENEM PHARMACOKINETICS; PEAK CONCENTRATION; SEPTIC PATIENTS; PHARMACODYNAMICS;
D O I
10.1097/MCC.0b013e32835685ad
中图分类号
R4 [临床医学];
学科分类号
100218 [急诊医学];
摘要
Purpose of review Antibiotic dosing for critically ill patients that is derived from other patient groups is likely to be suboptimal because of significant antibiotic pharmacokinetic changes, particularly in terms of drug volume of distribution and clearance. Organ support techniques including renal replacement therapy (RRT) and extracorporeal membrane oxygenation (ECMO) increase the pharmacokinetic variability. This article reviews the recently published antibiotic pharmacokinetic data associated with burns patients, those receiving continuous RRT (CRRT), sustained low-efficiency dialysis (SLED) and ECMO. Recent findings These groups develop increases in volume of distribution that necessitate the use of higher initial doses to rapidly achieve therapeutic antibiotic concentrations. Burns patients have supranormal drug clearances requiring more frequent administration of antibiotics. Patients receiving CRRT or SLED have variable drug clearances related to different equipment and RRT settings at different institutions. ECMO presents a different challenge because there is such a dearth of data with higher than standard doses potentially required, even in the presence of end-organ failure. Summary In the context of such variable pharmacokinetics, a guideline approach to dosing remains elusive because of insufficient available data and, therefore, use of therapeutic drug monitoring should be considered advantageous where possible.
引用
收藏
页码:460 / 471
页数:12
相关论文
共 74 条
[1]
Once-Daily Amikacin Dosing in Burn Patients Treated with Continuous Venovenous Hemofiltration [J].
Akers, Kevin S. ;
Cota, Jason M. ;
Frei, Christopher R. ;
Chung, Kevin K. ;
Mende, Katrin ;
Murray, Clinton K. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2011, 55 (10) :4639-4642
[2]
In vivo pharmacodynamics of a new oxazolidinone (linezolid) [J].
Andes, D ;
van Ogtrop, ML ;
Peng, J ;
Craig, WA .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (11) :3484-3489
[3]
The importance of pharmacokinetic consultation of cefepime treatment for Pseudomonas aeruginosa bacteremia: a case report of severe thermal burn injury [J].
Aoki, Yosuke ;
Urakami, Toshiharu ;
Magarifuchi, Hiroki ;
Nagasawa, Zenzo ;
Nagata, Masaki ;
Fukuoka, Mami .
JOURNAL OF INFECTION AND CHEMOTHERAPY, 2011, 17 (03) :407-411
[4]
Bellmann R, 2010, INT J CLIN PHARM TH, V48, P243
[5]
Meropenem Dosing in Critically Ill Patients with Sepsis Receiving High-Volume Continuous Venovenous Hemofiltration [J].
Bilgrami, I. ;
Roberts, J. A. ;
Wallis, S. C. ;
Thomas, J. ;
Davis, J. ;
Fowler, S. ;
Goldrick, P. B. ;
Lipman, J. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2010, 54 (07) :2974-2978
[6]
Influence of burns on pharmacokinetics and pharmacodynamics of drugs used in the care of burn patients [J].
Blanchet, Benoit ;
Jullien, Vincent ;
Vinsonneau, Christophe ;
Tod, Michel .
CLINICAL PHARMACOKINETICS, 2008, 47 (10) :635-654
[7]
COMPARATIVE-STUDY WITH ENOXACIN AND NETILMICIN IN A PHARMACODYNAMIC MODEL TO DETERMINE IMPORTANCE OF RATIO OF ANTIBIOTIC PEAK CONCENTRATION TO MIC FOR BACTERICIDAL ACTIVITY AND EMERGENCE OF RESISTANCE [J].
BLASER, J ;
STONE, BB ;
GRONER, MC ;
ZINNER, SH .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1987, 31 (07) :1054-1060
[8]
Antibiotic dosing during sustained low-efficiency dialysis: Special considerations in adult critically ill patients [J].
Bogard, Kimberly N. ;
Peterson, Nicole T. ;
Plumb, Troy J. ;
Erwin, Michael W. ;
Fuller, Patrick D. ;
Olsen, Keith M. .
CRITICAL CARE MEDICINE, 2011, 39 (03) :560-570
[9]
Elimination of daptomycin in a patient with acute renal failure undergoing extended daily dialysis [J].
Burkhardt, Olaf ;
Joukhadar, Christian ;
Traunmueller, Friederike ;
Hadem, Johannes ;
Welte, Tobias ;
Kielstein, Jan T. .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2008, 61 (01) :224-225
[10]
Sulphobutylether-β-cyclodextrin accumulation in critically ill patients with acute kidney injury treated with intravenous voriconazole under extended daily dialysis [J].
Burkhardt, Olaf ;
Thon, Simone ;
Burhenne, Juergen ;
Welte, Tobias ;
Kielstein, Jan T. .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2010, 36 (01) :93-94